Soru

Zorluk: ZorGynecologic Oncology

Match each patient's clinical presentation and associated gynecologic neoplasm with the most likely underlying genetic mutation and hereditary syndrome.

  • A 45-year-old woman with endometrioid endometrial adenocarcinoma; her family history is notable for a brother with colon cancer at age 42 and an aunt with urothelial cancer.Defect in DNA mismatch repair genes (e.g., MLH1, MSH2) leading to microsatellite instability.
  • A 52-year-old woman with ascites and a pelvic mass, diagnosed with high-grade serous carcinoma of the fallopian tube. Her maternal grandmother died of breast cancer.Defect in homologous recombination repair genes (e.g., BRCA1, BRCA2).
  • A 35-year-old woman with a history of macrocephaly and multiple trichilemmomas, who is now diagnosed with early-onset endometrial carcinoma.Defect in a tumor suppressor gene on chromosome 10 (PTEN) regulating the PI3K/AKT/mTOR pathway.
  • A 22-year-old woman with dark blue macules on her buccal mucosa and lips, presenting with a sex cord tumor with annular tubules (SCTAT) of the ovary.Defect in a serine/threonine kinase gene on chromosome 19 (STK11/LKB1).

Cevap

The correct matches align Lynch syndrome with mismatch repair defects, Hereditary Breast and Ovarian Cancer (HBOC) with homologous recombination defects, Cowden syndrome with PTEN mutations, and Peutz-Jeghers syndrome with STK11 mutations, based on their classic syndromic presentations.
Each patient presentation provides classic phenotypic and familial clues that define a specific hereditary cancer syndrome with high risk for gynecologic malignancies. Recognizing these unique patterns allows for the precise matching of the clinical syndrome to its underlying genetic defect.

Adım Adım Çözüm

1
Analyze the clinical phenotype and family history in each vignette to identify the specific hereditary cancer syndrome.
Identified Lynch syndrome, HBOC, Cowden syndrome, and Peutz-Jeghers syndrome.
Hereditary syndromes often present with distinctive non-gynecologic features (e.g., mucocutaneous lesions) or specific patterns of familial malignancies.
2
Recall the underlying genetic mutation and pathogenesis for each identified syndrome.
Lynch maps to MMR genes, HBOC to BRCA1/2, Cowden to PTEN, and Peutz-Jeghers to STK11.
Understanding the molecular basis of these syndromes is critical for genetic counseling, targeted therapies (e.g., PARP inhibitors for BRCA), and prophylactic surgeries.
3
Match each presentation to the correct corresponding genetic mechanism.
Successfully paired the left and right items based on established genotype-phenotype correlations.
Completes the diagnostic assessment linking clinical presentation to molecular pathology.

Anahtar Kavram

Hereditary cancer syndromes and their associated genetic mutations in gynecologic oncology.
Bu soruyu puanla